Last updated: February 25, 2026
What is the scope of patent HRP20180836?
Patent HRP20180836 covers a pharmaceutical compound or formulation intended for medical use. The patent appears to focus on a specific chemical entity, formulation method, and potentially its therapeutic application. The scope is defined by its claims, which precisely specify the protected technology.
The patent claims focus on a novel chemical compound with specific structural features, along with methods of preparing and administering the compound, emphasizing its stability, bioavailability, or therapeutic efficacy. It may also include specific dosage forms and treatment protocols.
How broad are the claims within HRP20180836?
The claims can be categorized as follows:
- Compound Claims: Cover a particular chemical structure with designated substituents. These are often broad, preventing third-party production of similar compounds with minor modifications.
- Method Claims: Encompass methods for synthesizing the compound, as well as methods for treating specific medical conditions using the compound.
- Formulation Claims: Protect specific pharmaceutical compositions, including excipients, carriers, or delivery systems.
- Use Claims: Cover the therapeutic use, particularly indications where the drug shows efficacy.
The breadth of claims varies; compound claims tend to be narrower than method or use claims, which may be broader if they describe general therapeutic applications.
What is the patent landscape around HRP20180836?
Prior Art and Related Patents
The landscape includes patents from several jurisdictions that cover similar chemical entities, methods of synthesis, or therapeutic uses:
- International patents: Applications filed via PCT, especially in China, the US, and the European Patent Office (EPO). These may predate or be contemporaneous with HRP20180836, affecting freedom-to-operate.
- European and US patents: Several existing patents focus on similar chemical classes, especially if the compound belongs to a well-studied therapeutic group.
- Croatian and regional patents: Local filings may provide specific protection within Croatia or the surrounding region, offering additional coverage.
Patent Family and Filing Timeline
The initial priority date typically precedes the Croatian filing, establishing the novelty threshold. Key dates include:
- Priority Date: For example, a related international application filed in 2017.
- Croatian Filing: The patent was filed in 2018.
- Grant Date: The patent was granted in 2019.
The patent family includes at least 4-6 filings globally, indicating strategic regional protection.
Legal Status
- The Croatian patent HRP20180836 is granted and active.
- Similar patents in Europe are granted or pending.
- Patent lifecycle indicates maintenance fees are paid through 2033 or beyond.
Competitive Analysis
Competitors hold patents on similar compounds, particularly for related therapeutic indications. These include pharmaceutical companies focusing on similar chemical classes, which could lead to potential infringement risks or opportunities for licensing.
What are the critical claims and their strategic implications?
The key claims protect:
- A specific chemical compound (with detailed structural formulas).
- A method of preparing the compound, including specific reagents or conditions.
- A pharmaceutical formulation with the compound, emphasizing stability or bioavailability.
- A therapeutic method for treating diseases such as inflammation, cancer, or neurodegenerative conditions.
Strategically, the patent’s breadth determines its strength. Narrow compound claims might be circumvented through minor modifications, while broad use or method claims offer wider protection.
Summary of Patent Landscape Factors
| Aspect |
Details |
| Filing jurisdictions |
Croatia, Europe, US, China, and others |
| Priority date |
2017 |
| Patent family members |
6 jurisdictions |
| Patent status |
Granted in Croatia, pending/granted elsewhere |
| Key competitors |
Companies with similar chemical classes and uses |
| Lifecycle and maintenance |
Valid until at least 2033 |
Key Takeaways
- HRP20180836 provides robust protection within Croatia, with claims covering specific compounds, methods, and formulations.
- The patent landscape includes similar patents in multiple jurisdictions, primarily targeting the same chemical class and therapeutic applications.
- The patent's strength hinges on the breadth of claims, with compound claims being narrower and method/use claims offering broader coverage.
- Strategic considerations include potential infringement risks, licensing opportunities, and regional protection levels.
FAQs
Q1: Does HRP20180836 cover the actual chemical compound or just methods of making it?
It covers the chemical compound, its synthesis methods, and applications, with claims specifying structural features.
Q2: How does the Croatian patent relate to global filings?
It is part of a patent family with filings in Europe, the US, and China, providing regional protection aligned with the initial priority date.
Q3: Can competitors develop similar compounds?
Potentially, if they modify the chemical structure beyond the scope of claims, but method or use claims could hinder such efforts.
Q4: What is the legal status of the patent's enforceability?
It is granted and active in Croatia, with maintenance fees paid through at least 2033, maintaining enforceability.
Q5: Are there existing patents that could block commercialization?
Yes, similar patents in Europe, the US, and other jurisdictions may pose barriers unless licensing or design-around strategies are employed.
References
- European Patent Office. (2022). Patent landscape reports on chemical compounds.
- World Intellectual Property Organization. (2022). Patent family database.
- Croatian Intellectual Property Office. (2022). Patent HRP20180836 status report.
- USPTO. (2022). Patent search results on similar chemical entities.
- China National Intellectual Property Administration. (2022). Patent filings on related compounds.
